Abstract
Introduction

Systemic capillary leak syndrome (SCLS) is a rare but devastating disorder that was first described by Clarkson et al in 1960 (1). SCLS is characterized by recurrent episodes of increased capillary permeability, resulting in hypovolemic shock due to a marked shift of plasma, up to 70%, from the intravascular to the extravascular space. Laboratory features include hemoconcentration and hypoalbuminemia, often with an associated monoclonal gammopathy without any evidence of multiple myeloma (2). Currently, about 57 cases have been reported, 12 of whom died of the disease during follow-up (3). Development of compartment syndrome by swelling of a massive muscular compartment is an uncommon complication of SCLS
. We describe a case of SCLS associated with pretibial compartment syndrome.
Case Report
In (8) .
In the present case, acute pulmonary edema was not observed during three SCLS episodes. However, Chihara et al reported the case of SCLS who developed acute pulmonary edema on hospital day 3. They speculate that intravascular overloading accompanied by the recruitment of the initially extravasated fluids and macromolecules resulted in acute pulmonary edema (9) . Their case indicates the importance of timely switch from the management of severe hypovolemia to that of acute fluid overload when the recruitment phase starts (10) . If kidney function is compromised, hemodialysis or hemofiltration should be done (10) .
We treated the present patient with steroid pulse therapy in the second SCLS episode. Corticosteroid may have a role when cytokine-mediated endothelial damage initiates the capillary leak (9, 10) . Tahirkheli and Greipp (2) and Droder et al (11) showed that treatment with terbutaline and theophylline caused episodes of the SCLS to completely abate in some patients and decreased the incidence and severity of episodes in others. Terbutaline and theophylline diminish the increment of capillary permeability induced by bradykinin, by an increase of cyclic adenosine monophospate (5) .
Prolonged survival may provide more time for progression to multiple myeloma. Two patients who progressed to multiple myeloma after the diagnosis of SCLS were reported (12) . In patients with monoclonal gammopathy of undetermined significance, the actuarial risk of myeloma at 25 years follow-up is 30% and actual risk is 11% (13 
